umoja-biopharma.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $921.51MM
Umoja Biopharma is a clinical-stage biotechnology company that develops a new class of cancer therapies that are designed to be highly potent and selective against tumors.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/03/2024 | Series C | $100MM | $xx.xx | $421.69MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
25,285,601
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/15/2021 | Series B1 | $89,351 | $xx.xx | $673.33MM | SoftBank Vision Fund 2, Cormorant Asset Management, TRW Investments LP, Temasek, Presight Capital, Caas Capital, SVB Leerink, MPM Capital, DCVC Bio, Qiming Venture Partners USA, Casdin Capital, Emerson Collective, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
11,337
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
SoftBank Vision Fund 2, Cormorant Asset Management, TRW Investments LP, Temasek, Presight Capital, Caas Capital, SVB Leerink, MPM Capital, DCVC Bio, Qiming Venture Partners USA, Casdin Capital, Emerson Collective, Alexandria Venture Investments
|
||||||
06/15/2021 | Series B | $210.37MM | $xx.xx | $673.33MM | SoftBank Vision Fund 2, Cormorant Asset Management, TRW Investments LP, Temasek, Presight Capital, Caas Capital, SVB Leerink, MPM Capital, DCVC Bio, Qiming Venture Partners USA, Casdin Capital, Emerson Collective, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
21,354,056
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
SoftBank Vision Fund 2, Cormorant Asset Management, TRW Investments LP, Temasek, Presight Capital, Caas Capital, SVB Leerink, MPM Capital, DCVC Bio, Qiming Venture Partners USA, Casdin Capital, Emerson Collective, Alexandria Venture Investments
|
||||||
11/18/2020 | Series A2 | $28.19MM | $xx.xx | $110.79MM | MPM Capital, Qiming Venture Partners USA | |
Price per Share
$xx.xx
Shares Outstanding
10,353,412
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, Qiming Venture Partners USA
|
||||||
11/18/2020 | Series A1 | $176,334 | $xx.xx | $110.79MM | MPM Capital, Qiming Venture Partners USA | |
Price per Share
$xx.xx
Shares Outstanding
122,710
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, Qiming Venture Partners USA
|
||||||
11/18/2020 | Series A | $27MM | $xx.xx | $110.79MM | MPM Capital, Qiming Venture Partners USA | |
Price per Share
$xx.xx
Shares Outstanding
15,034,465
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, Qiming Venture Partners USA
|
||||||
02/05/2019 | Series Seed-1 | $1.27MM | $xx.xx | $23.76MM | MPM Capital, DCVC Bio | |
Price per Share
$xx.xx
Shares Outstanding
565,996
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, DCVC Bio
|
||||||
02/05/2019 | Series Seed | $6.73MM | $xx.xx | $23.76MM | MPM Capital, DCVC Bio | |
Price per Share
$xx.xx
Shares Outstanding
2,400,773
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, DCVC Bio
|